— Publications

First Quarter 2019 Results 




All financial reports


— Media releases


June 20, 2019

Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D

Read more


— Upcoming events


Annual General Meeting
June 27, 2019, Paris
Read more

Valneva R&D Investor Day
July 9, 2019, New York City
Read more


All dates




— Lyme Disease

Download brochure









    

— Our responsibility

Committed to people, protecting lives and the environment


Learn more

play video
“We have the only
clinical-stage vaccine program
against Lyme disease 
worldwide.”

Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter

mail-icon-lightblue.png


Contact Investor Relations

speech-balloon-icon-white.png

Please update your browser...